🇺🇸 FDA
Pipeline program

DEXAMETHASONE PHOSPHATE, Placebo of dexamethasone

APHP220674

Phase 3 small_molecule active

Quick answer

DEXAMETHASONE PHOSPHATE, Placebo of dexamethasone for respiratory distress due to upper airway obstruction in child is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Pari Pharma GmbH
Indication
respiratory distress due to upper airway obstruction in child
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials